AnaptysBio Investigational Arthritis Drug Might Have Better Efficacy Profile Than Eli Lilly's: Analyst
Morphic Holding Analyst Ratings
AnaptysBio Analyst Ratings
TSLA-related ETFs Among Top Performing ETFs on a 4-week Performance Base Last Week
ORIC Collaborates With Bayer, J&J on Prostate Cancer Study
Cantor Fitzgerald Reiterates Overweight on UniQure, Maintains $24 Price Target
XPeng & QuantumScape Are Among Top 11 Mid Cap Stocks That Performed Well Last Week (July 7-July 13): Details
Russell 2000 Index Notches Strongest Week Of Year, Hits 31-Month Highs: Outlook Is 'Clouded By Fed's Concerns Over Labor Market,' Analyst Warns
Why ConAgra Brands Shares Are Trading Lower? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Baird Maintains Outperform on Longboard Pharmaceuticals, Raises Price Target to $60
Longboard Pharmaceuticals Analyst Ratings
Why Are UniQure Shares Surging Today?
ORIC Pharmaceuticals Analyst Ratings
Why SeaStar Medical Holding Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
SMART Global Posts Upbeat Results, Joins Aehr Test Systems, MarineMax And Other Big Stocks Moving Higher On Wednesday
Kura Sushi Posts Weak Q3 Results, Joins LegalZoom.com And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
BMO Sees BMRN, LEGN, SLN as Attractive M&A Targets
Eli Lilly's $3.2B Morphic Deal Is 'Crucial,' Has 'Strategic Merit' Despite Investor Attention On Obesity: Analyst
Why Helen of Troy Shares Are Trading Lower By Around 30%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Why UniQure Stock Is Soaring